Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J AAPOS. 2011 Oct;15(5):455–461. doi: 10.1016/j.jaapos.2011.06.007

Table 1.

Description of protocols included in the baseline and outcome stereoacuity analyses

Study Na Treatment groups Age Visual acuity
testing
Baseline
amblyopia
severity
Outcome
stereoacuity
exam
15 130b Patching ± atropine
Optical correction alone
7 to <18 E-ETDRS 20/40–20/100
26 64b Daily atropine
Weekend atropine
3 to <7 ATS-HOTV 20/40–20/80
37 74 2-hour patching
Glasses alone
3 to <7 ATS-HOTV 20/40–20/100
48 158 (141) 2-hour patching + near activities
2-hour patching + distance activities
3 to <7 ATS-HOTV 20/40–20/100 17 ± 1 week
59 60 Weekend atropine
Weekend atropine + plano lens
3 to <7 ATS-HOTV 20/40–20/100
610 74 (40) 2-hour patching
Weekend atropine
7 to <13 E-ETDRS 20/40–20/100 17 ± 1 week
711 73 (67) 2-hour patching
Bangerter (full-time)
3 to <10 ATS-HOTV
E-ETDRS
20/40–20/80 24 ± 2 weeks

ATS-HOTV, Amblyopia Treatment Study HOTV; E-ETDRS, Electronic Early Treatment for Diabetic Retinopathy Study.

a

Sample sizes are based on the cohort included in the baseline stereoacuity analysis; sample sizes enclosed within the parentheses indicate the number of subjects included in the outcome stereoacuity analysis from specific protocols.

b

Stability of visual acuity in glasses not required for study eligibility at enrollment.